Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9452227
SERIAL NO

12624778

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of anti-IL-6 antibodies or antibody fragments containing a specific epitopic specificity to treat conditions involving elevated Il-6. In some embodiments the anti-IL-6 antibodies contain specific CDRs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ALDERBIO HOLDINGS LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dutzar, Ben Seattle, US 10 819
Garcia-Martinez, Leon Woodinville, US 21 817
Jensen, Anne Elisabeth Carvalho Edmonds, US 11 785
Kovacevich, Brian Snohomish, US 37 1651
Latham, John Seattle, US 105 3011
Litton, Mark Seattle, US 24 582
Olson, Katie Kenmore, US 15 1014
Schatzman, Randall Redmond, US 18 517
Smith, Jeffrey T L Redmond, US 93 1198

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 27, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 27, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00